期刊文献+

乌司他丁在体外循环心脏手术中对心肌的保护作用

Protective Effect of Ulinastatin on Myocardium in Cardiopulmonary Bypass Surgery
在线阅读 下载PDF
导出
摘要 目的使用乌司他丁对体外循环心脏手术中对心肌进行保护,并对其对心肌的保护作用进行评价。方法选取我院接受风湿性心脏病治疗的患者65例,其中35例患者在手术过程中使用乌司他丁,剩余的30例患者未使用乌司他丁,前者作为观察组,后者作为对照组。比较两组患者的IL-6、IL8、TNF-α、LDH、CK-MB、eTnl水平,记录两组患者心脏复跳及术后患者正性肌力作用药物的使用量。并将两组患者的各项数值指标使用SPSS统计学软件进行t检验,取P=0.05。结果治疗组患者的心肌细胞较对照组心肌细胞保护明显,统计学结果P<0.05,具有统计学意义。结论乌司他丁在体外循环心脏手术中对患者的心肌可以起到明显的保护作用。 Objective Protective effect of ulinastatin on myocardium in cardiopulmonary bypass surgery,and the role of myocardial protection are evaluated.Methods Select our trouble rheumatic heart disease patients treated accept 65,among them 35 patients during the operation used ulinastatin,the rest of the 30 patients did not use the ulinastatin,the former as research group,the latter as control group.Compare two sets of patients IL-6,IL8,TNF alpha and LDH,CK-MB,eTnl level,two groups of patients heart after record jump and postoperative patients is sex role in the use of drugs muscle strength.And the two sets of patients use the numerical index software SPSS statistical t test,take P = 0.05.Results The treatment group of patients with a control group of myocardial cells myocardial cell protection obvious,statistical results P0.05,with statistical significance.Conclusion The ulinastatin open-heart surgery in patients of myocardial can rise to the apparent protectie effect.
作者 高兴贵
出处 《中国医药指南》 2012年第15期75-76,共2页 Guide of China Medicine
关键词 乌司他丁 IL-6 IL8 TNF-α LDH CK-MB T检验 Ulinastatin IL-6 IL8 TNF alpha LDH CK-MB T test
  • 相关文献

参考文献4

二级参考文献35

  • 1魏民新,简锴陶,郭志刚,王联群,李培军,韩建阁,蔡忠.非体外循环冠脉搭桥术血液保护的初步研究[J].天津医药,2006,34(2):73-75. 被引量:7
  • 2袁晓勇.立芷雪在脑外科手术中的疗效观察[J].中国处方药,2006,5(9):57-58. 被引量:4
  • 3刘中凯,王令平,陈永生,周廷发,张华,王朝晖,徐强.乌司他丁对体外循环心脏直视手术患者血液保护作用的临床研究[J].山东医学高等专科学校学报,2006,28(1):19-22. 被引量:5
  • 4张秀来,周海燕,王屹,彭全民,叶怀庄,杨小锋.乌司他丁对心肺转流心内直视手术患者围术期脑损伤的影响[J].中华创伤杂志,2007,23(6):432-435. 被引量:5
  • 5[1]Sato Y,Ishikawa S,Otaki A,et al.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury.Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 6[2]Conlon PJ,Stafford-Smith M,White WD,et al.Acute renal failure following cardiac surgery.Nephrol Dial Transplant,1999,14(5):1158-1162.
  • 7[3]Suen WS,Mok CK,Chiu SW,et al.Risk factors for development of acute renal failure(ARF) requiring dialysis in patients undergoing cardiac surgery.Angiology,1998,49(10):789-800.
  • 8[4]Oshima N,Yamada T,Nakahara H,et al.Effect of ulinastatin(UL) on renal function and lactic acidosis during open-heart surgery:comparison with aprotinin.Kyobu Geka,1990,43(5):357-363.
  • 9[5]Ueki M,Yokono S,Nogaya J,et al.Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass.Masui,1995,44(5):691-697.
  • 10[6]Yonoko S,Ueki M,Nakayo M,et al.Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass.Masui,1997,46(3):388-392.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部